Unaudited Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Dec. 30, 2011	Dec. 31, 2010
Cash Flows From Operating Activities:
Net income	$ 54,401	$ 53,067
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	19,828	18,301
Amortization of debt discount and issuance costs	7,588	7,019
Amortization of intangible assets	6,461	4,528
Noncash compensation expense	5,944	7,259
(Benefit) provision for deferred income taxes	(4,083)	778
Provision for doubtful accounts	1,633	1,748
Provision for deferred compensation	838	1,136
(Gain) loss on sales of property and equipment	(2)	19
Changes in operating assets and liabilities, net of effects from business combinations:
Accounts receivable, net	4,549	(3,039)
Inventories	(44,409)	(17,234)
Prepaid expenses and other current assets	(6,483)	(5,319)
Other assets	(10,180)	(6,339)
Accounts payable	28,065	16,082
Accrued expenses and other liabilities	1,819	(3,585)
Net cash provided by operating activities	65,969	74,421
Cash Flows From Investing Activities:
Payments for business acquisitions, net of cash acquired	(39,635)	(20,248)
Capital expenditures	(17,576)	(13,065)
Payment for investment in variable interest entity, net of cash	0	(3,277)
Other investing activities	(220)	(621)
Net cash used in investing activities	(57,431)	(37,211)
Cash Flows From Financing Activities:
Proceeds from borrowings on the revolving line of credit	325,783	17,150
Repayments on the revolving line of credit	(209,533)	(17,150)
Purchase and retirement of common stock	(115,760)	(54,713)
Payment of contingent consideration on business acquisitions	(4,000)	(862)
Payment of debt issuance costs	(1,835)
Excess tax benefits from share-based compensation arrangements	1,443	2,099
Payments under capital lease obligations	(577)	(590)
Proceeds from exercise of stock options	554	1,137
Other financing activities	(1,523)	(120)
Net cash used in financing activities	(5,448)	(53,049)
Net increase (decrease) in cash and cash equivalents	3,090	(15,839)
Cash and cash equivalents, beginning of period	29,348	52,751
Cash and cash equivalents, end of period	$ 32,438	$ 36,912